Format

Send to

Choose Destination
Eur J Nucl Med Mol Imaging. 2017 Dec;44(13):2302-2309. doi: 10.1007/s00259-017-3828-8. Epub 2017 Sep 13.

New horizons in cardiac innervation imaging: introduction of novel 18F-labeled PET tracers.

Author information

1
Department of Nuclear Medicine, University Hospital of Würzburg, Oberdürrbacher Strasse 6, 97080, Würzburg, Germany.
2
Research Centre, Nihon Medi-Physics Co., Ltd., Chiba, Japan.
3
Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany.
4
The Russell H Morgan Department of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.
5
Department of Nuclear Medicine, University Hospital of Würzburg, Oberdürrbacher Strasse 6, 97080, Würzburg, Germany. thiguchi@me.com.
6
Comprehensive Heart Failure Center, University Hospital of Würzburg, Würzburg, Germany. thiguchi@me.com.
7
Department of Biomedical Imaging, Research Institute, National Cerebral and Cardiovascular Center, Suita, Japan. thiguchi@me.com.

Abstract

Cardiac sympathetic nervous activity can be uniquely visualized by non-invasive radionuclide imaging techniques due to the fast growing and widespread application of nuclear cardiology in the last few years. The norepinephrine analogue 123I-meta-iodobenzylguanidine (123I-MIBG) is a single photon emission computed tomography (SPECT) tracer for the clinical implementation of sympathetic nervous imaging for both diagnosis and prognosis of heart failure. Meanwhile, positron emission tomography (PET) imaging has become increasingly attractive because of its higher spatial and temporal resolution compared to SPECT, which allows regional functional and dynamic kinetic analysis. Nevertheless, wider use of cardiac sympathetic nervous PET imaging is still limited mainly due to the demand of costly on-site cyclotrons, which are required for the production of conventional 11C-labeled (radiological half-life, 20 min) PET tracers. Most recently, more promising 18F-labeled (half-life, 110 min) PET radiopharmaceuticals targeting sympathetic nervous system have been introduced. These tracers optimize PET imaging and, by using delivery networks, cost less to produce. In this article, the latest advances of sympathetic nervous imaging using 18F-labeled radiotracers along with their possible applications are reviewed.

KEYWORDS:

18F-labeled radiotracer; Heart failure; Nuclear cardiology; PET; SPECT; Sympathetic nervous system

Comment in

PMID:
28905088
DOI:
10.1007/s00259-017-3828-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center